Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
Cutaneous metastases (CMs) account for 2% of all skin malignancies, and nearly 70% of CMs in women originate from breast cancer (BC). CMs are usually associated with poor prognosis, are difficult to treat, and can pose diagnostic problems, such as in histopathological diagnosis when occurring long a...
Main Authors: | Silvia González-Martínez, David Pizarro, Belén Pérez-Mies, Tamara Caniego-Casas, Giuseppe Curigliano, Javier Cortés, José Palacios |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/21/5416 |
Similar Items
-
Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases
by: Silvia González-Martínez, et al.
Published: (2022-02-01) -
Cutaneous metastasis as a first presentation of lung carcinoma: a case series
by: Saida Sakhri, et al.
Published: (2023-07-01) -
Cutaneous metastasis of urothelial carcinoma
by: Alexandra Baczynski, et al.
Published: (2024-01-01) -
Recurrent Breast Cancer with Cutaneous Metastasis in the Late Term
by: Serbülent Güzey, et al.
Published: (2017-03-01) -
Clinicopathologic features of cutaneous metastases from internal malignancies
by: Hyeong Mok Kwon, et al.
Published: (2021-07-01)